Skip to main content

UBS Group AG

Position in CVM — Cel Sci Corp

CIK 1610520 ZURICH, V8

Position in CVM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,344
-$45,060 QoQ
Shares Held
8,025
-51.8% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 41 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in CVM Over Time

Shares Held

Position Value (USD)

Derivatives in CVM

reported options exposure · as of Jun 30, 2021
CallValue
$0
CallShares
0
PutValue
$13,769,951
PutShares
1,586,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,271,661 across 562 Biotechnology names. CVM ranks #458 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CVM

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,344 8,025
2026-03-31 $53,404 16,637
2025-12-31 $69,394 13,193
2025-09-30 $142,819 15,524
2025-06-30 $68,279 29,817
2025-03-31 $21,222 92,280
2024-12-31 $38,833 97,089
2024-09-30 $48,070 45,350
2024-06-30 $140,824 121,401
2024-03-31 $99,928 52,319
2023-12-31 $60,690 22,313
2023-09-30 $19,813 15,852
2023-06-30 $36,337 15,078
2023-03-31 $32,488 14,004
2022-12-31 $50,714 21,581
2022-09-30 $22,695 7,345
2022-06-30 $22,489 4,998
2022-03-31 $24,306 6,185
2021-12-31 $1,543,105 217,339
2021-09-30 $2,546,778 231,736
2021-06-30 $13,769,951 1,586,400
2021-06-30 $221,539 25,523
2021-03-31 $12,329,225 810,600
2021-03-31 $1,299,846 85,460
2020-12-31 $104,461 8,959
2020-12-31 $232,033 19,900
2020-09-30 $74,012 5,805
2020-06-30 $733,197 49,142
2020-06-30 $745,999 50,000
2020-03-31 $236,789 20,519